al-Roomi K, Heller R F, Holland T, Floate D, Wlodarczyk J
Centre for Clinical Epidemiology and Biostatistics, Royal Newcastle Hospital, NSW.
Med J Aust. 1992 Oct 5;157(7):452-5.
To determine the importance of hypertension in the aetiology of infarctive and haemorrhagic stroke in persons aged 35-69 years.
A population-based case-control study.
Lower Hunter Region community.
One hundred and ninety patients with a first stroke were identified from a register, including all hospital admissions and death certificates in the Region, and compared with 496 control subjects obtained from a random population sample of the same community.
First event of stroke (fatal or non-fatal).
Twenty-seven per cent of those with a haemorrhagic stroke, compared with 2% of those with infarctive stroke, died before hospital admission; the in-hospital mortality was 15% and 9%, respectively. Twenty-one per cent of control subjects, compared with 51% of those with stroke, were currently receiving treatment for hypertension. By logistic regression analysis the odds ratio for receiving current treatment for hypertension in those with haemorrhagic stroke was 5.5 (95% confidence interval [CI], 2.36-12.8), compared with 2.53 (95% CI, 1.48-4.34) in those with infarctive stroke. Other differences between haemorrhagic and infarctive stroke included no excess risk in men for haemorrhagic stroke but an odds ratio of 3.51 (95% CI, 1.83-6.74) for infarctive stroke; and a steep risk gradient for obesity in haemorrhagic but not in infarctive stroke. Cigarette smoking carried a non-significant odds ratio of around 1.5, with no difference between stroke type. Among those who had ever been told that they had hypertension, 75% and 71% of patients with infarctive stroke and haemorrhagic stroke, respectively, and 61% of control subjects, were currently receiving treatment for hypertension. In those stroke patients who were currently being treated for hypertension, 63% had a pre-admission diastolic blood pressure of 90 mmHg or more. The mean diastolic blood pressure levels on admission were 10 mmHg higher than the latest recorded pre-hospital measurements and fell to 10 mmHg lower than the levels recorded before hospital admission by the time of discharge.
Hypertension is important in the aetiology of both infarctive and haemorrhagic strokes, although it may be more important in haemorrhagic stroke, and there appear to be other aetiological differences between stroke types. Most of the patients with a history of hypertension were currently receiving treatment for hypertension, although blood pressure control before admission was not optimal.
确定高血压在35 - 69岁人群梗死性和出血性卒中病因中的重要性。
一项基于人群的病例对照研究。
下亨特地区社区。
从一份登记册中识别出190例首次发生卒中的患者,包括该地区所有住院病例和死亡证明,并与从同一社区随机抽取的496名对照者进行比较。
首次卒中事件(致命或非致命)。
出血性卒中患者中有27%在入院前死亡,而梗死性卒中患者中这一比例为2%;住院死亡率分别为15%和9%。对照者中有21%正在接受高血压治疗,而卒中患者中有51%正在接受治疗。通过逻辑回归分析,出血性卒中患者目前接受高血压治疗的比值比为5.5(95%置信区间[CI],2.36 - 12.8),梗死性卒中患者为2.53(95% CI,1.48 - 4.34)。出血性卒中和梗死性卒中的其他差异包括:出血性卒中男性无额外风险,而梗死性卒中的比值比为3.51(95% CI,1.83 - 6.74);出血性卒中肥胖风险梯度大,而梗死性卒中无此情况。吸烟的比值比约为1.5,无统计学意义,且卒中类型之间无差异。在曾被告知患有高血压的人群中,梗死性卒中患者和出血性卒中患者分别有75%和71%以及对照者中有61%目前正在接受高血压治疗。在目前正在接受高血压治疗的卒中患者中,63%入院前舒张压≥90 mmHg。入院时平均舒张压水平比最新记录的院前测量值高10 mmHg,出院时比入院前记录的水平低10 mmHg。
高血压在梗死性和出血性卒中病因中均很重要,尽管在出血性卒中中可能更重要,且卒中类型之间似乎存在其他病因差异。大多数有高血压病史的患者目前正在接受高血压治疗,尽管入院前血压控制并不理想。